A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria

<i>Plasmodium vivax</i> malaria continues to cause a significant burden of disease in the Asia-Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8-aminoquinoline drugs are crucial for the complete removal of the parasite from the human host (radi...

Full description

Bibliographic Details
Main Authors: Arkasha Sadhewa, Sarah Cassidy-Seyoum, Sanjaya Acharya, Angela Devine, Ric N. Price, Muthoni Mwaura, Kamala Thriemer, Benedikt Ley
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pathogens
Subjects:
<i>P. vivax</i>
G6PD testing
radical cure
malaria elimination
policy
treatment guidelines
Online Access:https://www.mdpi.com/2076-0817/12/5/650

Internet

https://www.mdpi.com/2076-0817/12/5/650

Similar Items